Comparative Immunogenicity Study of Two Hepatitis A Vaccines

Status Enrolling by invitation

Clinical Trial Summary

Hepatitis A is the most prevalent hepatitis which account for approximately 45% . The susceptible population is Children and adolescence, also the morbidity in adult presented rising trend in recent years. Therefore, vaccination of Hepatitis A Vaccine play an important role in National Immunisation Program(China). The aim of this experiment is to verify the effects of experimental group non-inferior than control group. The experiment methods is compared the difference of seroconversion rate and Antibody geometric mean titer (GMT)between experimental and control Hepatitis A Vaccines. In addition, evaluating the safety of two Hepatitis A Vaccines in 18-24 months Chinese Children.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03231605
Study type	Interventional
Source	China National Biotec Group Company Limited
Contact
Status	Enrolling by invitation
Phase	Phase 4
Start date	July 26, 2017
Completion date	December 29, 2017

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03445416` - Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men	N/A
Completed	`NCT01949857` - The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines	Phase 4
Completed	`NCT00313950` - Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine	Phase 4
Completed	`NCT00139139` - A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A	N/A
Completed	`NCT00197171` - Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine	Phase 3
Completed	`NCT00139113` - Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children	Phase 4
Completed	`NCT03312699` - Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort	Phase 1
Completed	`NCT03855176` - Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients	Phase 4
Completed	`NCT00197002` - Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age	Phase 3
Withdrawn	`NCT02605538` - Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively	N/A
Completed	`NCT04638335` - What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years
Completed	`NCT00197015` - Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children	Phase 3
Active, not recruiting	`NCT06058416` - Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old	Phase 4
Completed	`NCT01453348` - Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine	Phase 3
Completed	`NCT01865968` - Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults	Phase 4
Completed	`NCT02002065` - The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children	N/A
Terminated	`NCT00119743` - A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine	Phase 3
Completed	`NCT01000324` - Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult	Phase 4
Completed	`NCT00289731` - Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc	Phase 4
Completed	`NCT02300792` - The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A	Phase 2